Cite
Gornalusse GG, Vojtech LN, Levy CN, et al. Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses. 2021;13(8)doi: 10.3390/v13081472.
Gornalusse, G. G., Vojtech, L. N., Levy, C. N., Hughes, S. M., Kim, Y., Valdez, R., Pandey, U., Ochsenbauer, C., Astronomo, R., McElrath, J., & Hladik, F. (2021). Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses, 13(8), . https://doi.org/10.3390/v13081472
Gornalusse, Germán Gustavo, et al. "Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency." Viruses vol. 13,8 (2021). doi: https://doi.org/10.3390/v13081472
Gornalusse GG, Vojtech LN, Levy CN, Hughes SM, Kim Y, Valdez R, Pandey U, Ochsenbauer C, Astronomo R, McElrath J, Hladik F. Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses. 2021 Jul 27;13(8). doi: 10.3390/v13081472. PMID: 34452338; PMCID: PMC8402857.
Copy
Download .nbib